Amgen 2012 Annual Report Download - page 92

Download and view the complete annual report

Please find page 92 of the 2012 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 150

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150

85
Exhibit No. Description
10.25+ Agreement between Amgen Inc. and Mr. Jonathan M. Peacock, dated July 5, 2010. (Filed as an exhibit to
Form 10-Q for the quarter ended September 30, 2010 on November 8, 2010 and incorporated herein by
reference.)
10.26+ Agreement between Amgen Inc. and Mr. Anthony C. Hooper, dated October 12, 2011. (Filed as an exhibit
to Form 10-K for the year ended December 31, 2011 on February 29, 2012 and incorporated herein by
reference.)
10.27+ Consulting Services Agreement, effective February 13, 2012, between Amgen Inc., Perlmutter Consulting,
Inc. and Dr. Roger M. Perlmutter. (Filed as an exhibit to Form 8-K on March 1, 2012 and incorporated
herein by reference.)
10.28+ Grant Agreement, dated December 3, 2012, between Amgen Inc., and Reed College. (Filed as an exhibit
to Form 8-K on December 7, 2012 and incorporated herein by reference.)
10.29+ Restricted Stock Unit Agreement, dated April 27, 2012, between Amgen Inc. and Kevin W. Sharer. (Filed
as an exhibit to Form 10-Q for the quarter ended June 30, 2012 on August 8, 2012 and incorporated herein
by reference.)
10.30+ Performance Unit Agreement, dated April 27, 2012, between Amgen Inc. and Kevin W. Sharer. (Filed as
an exhibit to Form 10-Q for the quarter ended June 30, 2012 on August 8, 2012 and incorporated herein
by reference.)
10.31 Product License Agreement, dated September 30, 1985, and Technology License Agreement, dated,
September 30, 1985 between Amgen and Ortho Pharmaceutical Corporation. (Filed as an exhibit to Form
10-Q for the quarter ended June 30, 2000 on August 1, 2000 and incorporated herein by reference.)
10.32 Shareholders’ Agreement, dated May 11, 1984, among Amgen, Kirin Brewery Company, Limited and
Kirin-Amgen, Inc. (Filed as an exhibit to Form 10-K for the year ended December 31, 2000 on March 7,
2001 and incorporated herein by reference.)
10.33 Amendment No. 1 dated March 19, 1985, Amendment No. 2 dated July 29, 1985 (effective July 1, 1985),
and Amendment No. 3, dated December 19, 1985, to the Shareholders’ Agreement dated May 11, 1984.
(Filed as an exhibit to Form 10-Q for the quarter ended June 30, 2000 on August 1, 2000 and incorporated
herein by reference.)
10.34 Amendment No. 4 dated October 16, 1986 (effective July 1, 1986), Amendment No. 5 dated December 6,
1986 (effective July 1, 1986), Amendment No. 6 dated June 1, 1987, Amendment No. 7 dated July 17,
1987 (effective April 1, 1987), Amendment No. 8 dated May 28, 1993 (effective November 13, 1990),
Amendment No. 9 dated December 9, 1994 (effective June 14, 1994), Amendment No. 10 effective March
1, 1996, and Amendment No. 11 effective March 20, 2000 to the Shareholders’ Agreement, dated May 11,
1984. (Filed as exhibits to Form 10-K for the year ended December 31, 2000 on March 7, 2001 and
incorporated herein by reference.)
10.35 Amendment No. 12 to the Shareholders’ Agreement, dated January 31, 2001. (Filed as an exhibit to Form
10-Q for the quarter ended June 30, 2005 on August 8, 2005 and incorporated herein by reference.)
10.36 Amendment No. 13 to the Shareholders’ Agreement, dated June 28, 2007 (with certain confidential
information deleted therefrom). (Filed as an exhibit to Form 10-Q for the quarter ended June 30, 2007 on
August 9, 2007 and incorporated herein by reference.)
10.37 Product License Agreement, dated September 30, 1985, and Technology License Agreement, dated
September 30, 1985, between Kirin-Amgen, Inc. and Ortho Pharmaceutical Corporation. (Filed as an
exhibit to Form 10-Q for the quarter ended June 30, 2000 on August 1, 2000 and incorporated herein by
reference.)
10.38 Research, Development Technology Disclosure and License Agreement: PPO, dated January 20, 1986, by
and between Kirin Brewery Co., Ltd. and Amgen Inc. (Filed as an exhibit to Amendment No. 1 to Form
S-1 Registration Statement on March 11, 1986 and incorporated herein by reference.)
10.39 Assignment and License Agreement, dated October 16, 1986 (effective July 1, 1986), between Amgen and
Kirin-Amgen, Inc. (Filed as an exhibit to Form 10-K for the year ended December 31, 2000 on March 7,
2001 and incorporated herein by reference.)